Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary

Tumor Biology

Volumn 32, Issue 5, 2011, Pages 893-904

  Koo, Ja Seung ^a   Kim, Haeryoung ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Cancer; Hypoxia; Immunohistochemistry; Unknown primary

Indexed keywords

ANTINEOPLASTIC AGENT; CAVEOLIN 1; CELL PROTEIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GLUCOSE TRANSPORTER 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN 14 3 3; PROTEIN KINASE B; PROTEIN P53; PROTEIN REDD1; PROTEIN RRM1; PROTEIN S6; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA; CARCINOMATOSIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE NEU; OVERALL SURVIVAL; POORLY DIFFERENTIATED CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TUMOR MICROENVIRONMENT; UNDIFFERENTIATED CARCINOMA;

EID: 80052334435     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0190-5     Document Type: Article

References (30)

1. N Pavlidis K Fizazi 2005 Cancer of unknown primary (CUP) Crit Rev Oncol Hematol 54 243 50 15890271 10.1016/j.critrevonc.2004.10.002 (Pubitemid 40693686)
2. CM Haskell AJ Cochran SH Barsky RJ Steckel 1988 Metastasis of unknown origin Curr Probl Cancer 12 5 58 3067982 10.1016/S0147-0272(88)80007-2 1:STN:280:DyaL1M7lt1ehug%3D%3D
3. ET Krementz EJ Cerise DS Foster LR Morgan Jr 1979 Metastases of undetermined source Curr Probl Cancer 4 4 37 391494 10.1016/S0147-0272(79)80019- 7 1:STN:280:DyaL3c%2FptV2hsw%3D%3D
4. BC Lembersky LC Thomas 1996 Metastases of unknown primary site Med Clin North Am 80 153 71 8569295 10.1016/S0025-7125(05)70433-8 1:STN:280: DyaK287htVymtw%3D%3D (Pubitemid 26008059)
5. F Levi VC Te G Erler L Randimbison C La Vecchia 2002 Epidemiology of unknown primary tumours Eur J Cancer 38 1810 2 12175699 10.1016/S0959-8049(02) 00135-1 1:STN:280:DC%2BD38vitFKmug%3D%3D
6. AJ van de Wouw ML Janssen-Heijnen JW Coebergh HF Hillen 2002 Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in southeast netherlands, 1984-1992 Eur J Cancer 38 409 13 11818207 10.1016/S0959-8049(01)00378-1 (Pubitemid 34121969)
7. AJ van de Wouw RL Jansen EJ Speel HF Hillen 2003 The unknown biology of the unknown primary tumour: A literature review Ann Oncol 14 191 6 12562643 10.1093/annonc/mdg068 (Pubitemid 36305428)
8. G Pentheroudakis E Briasoulis V Karavassilis G Fountzilas N Xeros G Samelis E Samantas N Pavlidis 2005 Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: Active, but how effective? Acta Oncol 44 155 60 15788295 10.1080/02841860510029554 (Pubitemid 40523374)
9. AC Wolff ME Hammond JN Schwartz KL Hagerty DC Allred RJ Cote M Dowsett PL Fitzgibbons WM Hanna A Langer LM McShane S Paik MD Pegram EA Perez MF Press A Rhodes C Sturgeon SE Taube R Tubbs GH Vance M van de Vijver TM Wheeler DF Hayes 2007 American society of clinical oncology/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 118 45 17159189 10.1200/JCO.2006.09.2775 1:CAS:528:DC%2BD2sXht1ejs7Y%3D (Pubitemid 350003059)
10. G Pentheroudakis N Pavlidis 2006 Perspectives for targeted therapies in cancer of unknown primary site Cancer Treat Rev 32 637 44 17046164 10.1016/j.ctrv.2006.08.004 1:CAS:528:DC%2BD28XhtFKlsrjK (Pubitemid 44645027)
11. JD Hainsworth WJ Lennington FA Greco 2000 Overexpression of her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site J Clin Oncol 18 632 5 10653878 1:STN:280:DC%2BD3c7itVyrsw%3D%3D (Pubitemid 30078544)
12. N Pavlidis E Briassoulis M Bai G Fountzilas N Agnantis 1995 Overexpression of c-myc, ras and c-erbb-2 oncoproteins in carcinoma of unknown primary origin Anticancer Res 15 2563 7 8669824 1:STN:280:DyaK283ntFeltg%3D%3D (Pubitemid 26098613)
13. NC Denko 2008 Hypoxia, hif1 and glucose metabolism in the solid tumour Nat Rev Cancer 8 705 13 19143055 10.1038/nrc2468 1:CAS:528:DC%2BD1cXhtVWksLfO
14. RA Gatenby RJ Gillies 2008 A microenvironmental model of carcinogenesis Nat Rev Cancer 8 56 61 18059462 10.1038/nrc2255 1:CAS:528:DC%2BD2sXhsVKku73J
15. R Moreno-Sanchez S Rodriguez-Enriquez A Marin-Hernandez E Saavedra 2007 Energy metabolism in tumor cells FEBS J 274 1393 418 17302740 10.1111/j.1742-4658.2007.05686.x 1:CAS:528:DC%2BD2sXjslait7g%3D (Pubitemid 46333738)
16. AD Ortega M Sanchez-Arago D Giner-Sanchez L Sanchez-Cenizo I Willers JM Cuezva 2009 Glucose avidity of carcinomas Cancer Lett 276 125 35 18790562 10.1016/j.canlet.2008.08.007 1:CAS:528:DC%2BD1MXisFKjsLw%3D
17. I Csiki K Yanagisawa N Haruki S Nadaf JD Morrow DH Johnson DP Carbone 2006 Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer Cancer Res 66 143 50 16397226 10.1158/0008-5472.CAN-05-1357 1:CAS:528:DC%2BD28XhsFWiug%3D%3D (Pubitemid 43166019)
18. A Kaidi D Qualtrough AC Williams C Paraskeva 2006 Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (hif)-1 promotes colorectal tumor cell survival and enhances hif-1 transcriptional activity during hypoxia Cancer Res 66 6683 91 16818642 10.1158/0008-5472.CAN-06-0425 1:CAS:528:DC%2BD28XmsVamurg%3D (Pubitemid 44085625)
19. M Legan B Luzar VF Marolt 2009 Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis Scand J Gastroenterol 44 1101 8 19606394 10.1080/00365520903121685
20. AW Eckert MH Lautner H Taubert J Schubert U Bilkenroth 2008 Expression of glut-1 is a prognostic marker for oral squamous cell carcinoma patients Oncol Rep 20 1381 5 19020718 1:STN:280:DC%2BD1cjltlehtg%3D%3D
21. YS Choi SJ Kim DS Kim SJ Park Y Park HJ Shin KY Jung SK Baek BK Shin JW Choi BS Kim SW Shin YH Kim JS Kim 2007 Glucose transporter-1 expression in squamous cell carcinoma of the tongue Cancer Res Treat 39 109 15 19746220 10.4143/crt.2007.39.3.109
22. S Pizzi A Porzionato C Pasquali D Guidolin C Sperti P Fogar V Macchi R De Caro S Pedrazzoli A Parenti 2009 Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis Histol Histopathol 24 175 85 19085834
23. M Endo U Tateishi K Seki U Yamaguchi F Nakatani A Kawai H Chuman Y Beppu 2007 Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas Jpn J Clin Oncol 37 955 60 18211986 10.1093/jjco/hym125 (Pubitemid 351176488)
24. R Bos P van der Groep AE Greijer A Shvarts S Meijer HM Pinedo GL Semenza PJ van Diest E van der Wall 2003 Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma Cancer 97 1573 81 12627523 10.1002/cncr.11246 (Pubitemid 36297788)
25. M Schindl SF Schoppmann H Samonigg H Hausmaninger W Kwasny M Gnant R Jakesz E Kubista P Birner G Oberhuber 2002 Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer Clin Cancer Res 8 1831 7 12060624 1:CAS:528:DC%2BD38Xlt1Crtbs%3D (Pubitemid 34633742)
26. C Trastour E Benizri F Ettore A Ramaioli E Chamorey J Pouyssegur E Berra 2007 Hif-1alpha and ca ix staining in invasive breast carcinomas: Prognosis and treatment outcome Int J Cancer 120 1451 8 17245699 10.1002/ijc.22436 1:CAS:528:DC%2BD2sXis12is7Y%3D (Pubitemid 46355379)
27. JJ Hung MH Yang HS Hsu WH Hsu JS Liu KJ Wu 2009 Prognostic significance of hypoxia-inducible factor-1alpha, twist1 and snail expression in resectable non-small cell lung cancer Thorax 64 1082 9 19778933 10.1136/thx.2009.115691
28. CM Chan BB Ma EP Hui SC Wong FK Mo SF Leung MK Kam AT Chan 2007 Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma - a prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor Oral Oncol 43 373 8 16979927 10.1016/j.oraloncology. 2006.04.004 1:CAS:528:DC%2BD2sXjtFKjt7o%3D (Pubitemid 46415794)
29. N Ogane M Yasuda M Shimizu M Miyazawa S Kamoshida A Ueda K Takata Y Sakuma Y Miyagi Y Kameda 2010 Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma Ann Diagn Pathol 14 23 29 20123453 10.1016/j.anndiagpath.2009.10.003
30. CZ Xu P Dong XY Li ZJ Zhang 2009 Expression and clinical significance of hypoxia-inducible factor-1alpha and cyclooxygenase-2 in laryngeal squamous cell carcinoma Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 44 57 62 19484991 1:CAS:528:DC%2BD1MXht1Omu7rN